Teva Pharmaceutical Industries ADR (TEVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 968,000 | 1,134,000 | -16,449,000 | -4,719,000 | -5,329,000 |
| Depreciation Amortization | 986,000 | 507,000 | 2,112,000 | 1,584,000 | 1,057,000 |
| Income taxes - deferred | -489,000 | -221,000 | -2,331,000 | -733,000 | -127,000 |
| Other Working Capital | -1,268,000 | -592,000 | -1,645,000 | -1,717,000 | -1,351,000 |
| Other Operating Activity | 1,461,000 | 668,000 | 20,538,000 | 6,951,000 | 6,321,000 |
| Operating Cash Flow | $1,658,000 | $1,496,000 | $2,225,000 | $1,366,000 | $571,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 542,000 | 661,000 | 2,603,000 | 1,000,000 | 1,090,000 |
| Net Acquisitions | N/A | N/A | 43,000 | 43,000 | N/A |
| Purchase Of Investment | -56,000 | -56,000 | -200,000 | -194,000 | -14,000 |
| Other Investing Activity | 959,000 | 434,000 | 1,000,000 | 685,000 | 354,000 |
| Investing Cash Flow | $1,445,000 | $1,039,000 | $3,446,000 | $1,534,000 | $1,430,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -261,000 | -261,000 | -1,683,000 | -1,630,000 | -1,477,000 |
| Debt Issued | 4,435,000 | -1,803,000 | -2,794,000 | 507,000 | 521,000 |
| Debt Repayment | -6,289,000 | N/A | N/A | -1,005,000 | -583,000 |
| Dividend Paid | N/A | -22,000 | -1,199,000 | -1,047,000 | -859,000 |
| Other Financing Activity | -32,000 | -5,000 | -74,000 | -69,000 | -21,000 |
| Financing Cash Flow | $-2,147,000 | $-2,091,000 | $-5,750,000 | $-3,244,000 | $-2,419,000 |
| Exchange Rate Effect | -58,000 | 11,000 | 54,000 | 36,000 | 29,000 |
| Beginning Cash Position | 963,000 | 963,000 | 988,000 | 988,000 | 988,000 |
| End Cash Position | 1,861,000 | 1,418,000 | 963,000 | 680,000 | 599,000 |
| Net Cash Flow | $898,000 | $455,000 | $-25,000 | $-308,000 | $-389,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,658,000 | 1,496,000 | 2,225,000 | 1,366,000 | 571,000 |
| Capital Expenditure | -299,000 | -163,000 | -874,000 | -607,000 | -395,000 |
| Free Cash Flow | 1,359,000 | 1,333,000 | 1,351,000 | 759,000 | 176,000 |